| Accession Number | 0001193125-26-305062 |
|---|---|
| Form Type | 4 |
| Filing Date | Jul 15, 2026 |
| Document | View SEC Filing |
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Scientific Officer | Class A Common Stock | โ | Jul 15, 2026 | Unknown | 22,393 | $124.00 | $2,776,732.00 | 0 | Direct | โ | View Details | |
Chief Scientific Officer | Class A Common Stock - Restricted Stock Units | โ | Jul 15, 2026 | Sale to Issuer | 41,100 | โ | โ | 0 | Direct | โ | View Details | |
Chief Scientific Officer | Class A Common Stock - Performance Stock Units | โ | Jul 15, 2026 | Grant/Award | 14,350 | $0.00 | $0.00 | 14,350 | Direct | โ | View Details | |
Chief Scientific Officer | Class A Common Stock - Performance Stock Units | โ | Jul 15, 2026 | Sale to Issuer | 14,350 | โ | โ | 0 | Direct | โ | View Details | |
Chief Scientific Officer | Stock Option (Right to Buy) | Derivative | Jul 15, 2026 | Sale to Issuer | 3,258 | โ | โ | 0 | Direct | โ | View Details | |
Chief Scientific Officer | Stock Option (Right to Buy) | Derivative | Jul 15, 2026 | Sale to Issuer | 2,113 | โ | โ | 0 | Direct | โ | View Details | |
Chief Scientific Officer | Stock Option (Right to Buy) | Derivative | Jul 15, 2026 | Sale to Issuer | 8,309 | โ | โ | 0 | Direct | โ | View Details | |
Chief Scientific Officer | Stock Option (Right to Buy) | Derivative | Jul 15, 2026 | Sale to Issuer | 9,900 | โ | โ | 0 | Direct | โ | View Details | |
Chief Scientific Officer | Stock Option (Right to Buy) | Derivative | Jul 15, 2026 | Sale to Issuer | 21,073 | โ | โ | 0 | Direct | โ | View Details | |
Chief Scientific Officer | Stock Option (Right to Buy) | Derivative | Jul 15, 2026 | Sale to Issuer | 18,600 | โ | โ | 0 | Direct | โ | View Details | |
Chief Scientific Officer | Stock Option (Right to Buy) | Derivative | Jul 15, 2026 | Sale to Issuer | 37,500 | โ | โ | 0 | Direct | โ | View Details | |
Chief Scientific Officer | Stock Option (Right to Buy) | Derivative | Jul 15, 2026 | Sale to Issuer | 17,500 | โ | โ | 0 | Direct | โ | View Details |